Top Markets
Coin of the day
Andros Pharmaceuticals Co.,Ltd Andros Pharmaceuticals Co.,Ltd

Andros Pharmaceuticals Co.,Ltd

6917
Classifica tra le azioni #24797
Andros Pharmaceuticals Co., Ltd. operates as a biopharmaceutical enterprise,... Andros Pharmaceuticals Co., Ltd. operates as a biopharmaceutical enterprise, concentrating on the advancement of novel drug delivery platform technologies. Its development pipeline features APC101, a metered-dose, quick-drying, film-forming spray undergoing Phase IIa clinical investigation for the management of pain linked to post-herpetic neuralgia. Also in development is APC201, an innovative topical anesthetic formulation currently in Phase I/II trials for Osteoarthritis treatment, alongside an siRNA (small interfering RNA) compound functioning as an antisense oligonucleotide and DNA candidate. In the preclinical phase, the company is advancing APC310 and APC501, both intended as anesthetics for intravenous catheter insertion and venipuncture. Another preclinical asset, APC401, is a specialized emulsified solution targeting post-surgical pain relief. Beyond its developmental programs, Andros Pharmaceuticals also provides LALP cream for dermal analgesic use, iMinos solution for treating Alopecia Androgenetica, and T4 endonuclease V. Established in 2008, the firm maintains its headquarters in Zhubei, Taiwan.
Prezzo delle azioni
$1.03
Capitalizzazione di mercato
$56.61M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
80.30%
Paese
TW
Scambia Andros Pharmaceuticals Co.,Ltd (6917)

Categoria

Storico del prezzo dell'azione per Andros Pharmaceuticals Co.,Ltd (6917)
Prezzo di chiusura più alto: $1.02 il 2026-08-01

Prezzo di chiusura più basso: $0.90 il 2023-01-01
Storico del prezzo dell'azione di Andros Pharmaceuticals Co.,Ltd dal 2023 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 2.61%
2025 51.47%
2024 -30.61%
2023 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$552.00 38.88%
US
$1.05K 58.34%
NL
$152.13 480.21%
US
$118.70 -18.24%
AU
$769.41 9.73%
CH